Clinical Trials Browser

Phase 2/3 × Recruiting × olaparib × Clear all

NCT05255653 2026-05-15

RAINBO

Phase 2/3 Recruiting

Endometrial Neoplasms

NCT03150576 2022-11-14

PARTNER

Phase 2/3 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms